# Type 2 Diabetes and Ambulatory Surgery Patients

Study · id `cardio:ct-nct03179254` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03179254](<https://clinicaltrials.gov/study/NCT03179254>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03179254

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

## Technical summary

Registry record NCT03179254. Randomized; no masking; primary purpose prevention. Start 2010-03-22 (actual); primary completion 2014-01-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 160 participants (enrolled count; ClinicalTrials.gov record NCT03179254, source copy `cardio:ctgov-nct03179254-2017-06-12`, retrieved 2026-10-26)
- Started: 2010-03-22 (actual) (ClinicalTrials.gov record NCT03179254, source copy `cardio:ctgov-nct03179254-2017-06-12`, retrieved 2026-10-26)
- Primary completion: 2014-01-10 (actual) (ClinicalTrials.gov record NCT03179254, source copy `cardio:ctgov-nct03179254-2017-06-12`, retrieved 2026-10-26)
- Completion: 2014-08-26 (actual) (ClinicalTrials.gov record NCT03179254, source copy `cardio:ctgov-nct03179254-2017-06-12`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03179254-2017-06-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Type 2 Diabetes and Ambulatory Surgery Patients
- Acronym: Diabetes
- Condition: Diabetes Type 2
- Intervention (Drug): Metformin continue
- Intervention (Drug): Metformin discontinue
- Lead sponsor: University of Texas Southwestern Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: University of Texas Southwestern Medical Center (`cardio:org-university-of-texas-southwestern-medical-center`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Preoperative Continuation Versus Interruption of Oral Hypoglycemics in Type 2 Diabetic Patients Undergoing Ambulatory Surgery: A Randomized Controlled Trial (`cardio:pubmed-30044293`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: cda833d728e3b0d235db73ef4df21bb68dee33a82cc0a79735368e41b2e52ee2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
